(Q46620396)

23 December 2017

title

Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study (English)

1 reference

23 December 2017

0 references

D S L Toh

1

1 reference

23 December 2017

L L Tan

2

1 reference

23 December 2017

D C W Aw

3

1 reference

23 December 2017

S M Pang

4

1 reference

23 December 2017

S H Lim

5

1 reference

23 December 2017

T Thirumoorthy

6

1 reference

23 December 2017

H Y Lee

7

1 reference

23 December 2017

Y K Tay

8

1 reference

23 December 2017

S K Tan

9

1 reference

23 December 2017

A Vasudevan

10

1 reference

23 December 2017

A Lateef

11

1 reference

23 December 2017

Y Y Chong

12

1 reference

23 December 2017

Y C Chan

13

1 reference

23 December 2017

C Loke

14

1 reference

23 December 2017

C L Chan

15

1 reference

23 December 2017

E S C Koay

16

1 reference

23 December 2017

E C Ren

17

1 reference

23 December 2017

E J D Lee

18

1 reference

23 December 2017

C Sung

19

1 reference

23 December 2017

publication date

7 January 2014

1 reference

23 December 2017

The Pharmacogenomics Journal

published in

1 reference

23 December 2017

volume

14

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

316-321

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/tpj.2013.46

exact match

0 references

cites work

Medical genetics: a marker for Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Phenotype standardization for immune-mediated drug-induced skin injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

HLA-B locus sequence-based typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Population-specific recombination sites within the human MHC region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

The innovative use of a large-scale industry biomedical consortium to research the genetic basis of drug induced serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

Pharmacogenetics: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2013.46

21 January 2018

Identifiers

DOI

10.1038/TPJ.2013.46

1 reference

23 December 2017

Dimensions Publication ID

1034531541

0 references

Fatcat ID

release_app2arfctfb3xn4nk5svceldxe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/app2arfctfb3xn4nk5svceldxe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 December 2017